Company name
Amporin Pharmaceuticals AG
Company profile
Amporin is an emerging Swiss biotech developing a new class of small molecule drugs that uniquely block and repair the holes in cell and mitochondrial membranes caused by misfolded proteins. By restoring membrane integrity, these therapies aim to restore normal cellular function, and thus stop or reverse more than 50 deadly degenerative diseases associated with protein misfolding and aggregation, including Alzheimer’s, Parkinson’s, type II diabetes, and many rare diseases.
Date, time and room information
Tuesday, May 5, 16:00 - 16:15, room Singapore
Category
Emerging biotech company
Title of the presentation
Amporin - Acute membrane repair for deadly degenerative diseases
Speaker information
| Name | Position | Institution |
|---|---|---|
| Kelvin Stott | Cofounder & CEO |
Further information for the sponsor website
